BNP Paribas Financial Markets
UTMD icon

BNP Paribas Financial Markets’s Utah Medical Products UTMD Stock Holding History

BNP Paribas Financial Markets’s Portfolio UTMD Stock Details UTMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$71.3K Sell
1,033
-172
-14% -$11.4K ﹤0.01% 4715
2026
Q1 		$74.7K Buy
1,205
+557
+86% +$35.1K ﹤0.01% 4510
2025
Q4 		$36.3K Sell
648
-412
-39% -$23.9K ﹤0.01% 4824
2025
Q3 		$66.7K Buy
1,060
+501
+90% +$29.6K ﹤0.01% 4471
2025
Q2 		$31.8K Sell
559
-1,169
-68% -$63.6K ﹤0.01% 4414
2025
Q1 		$96.8K Sell
1,728
-3,184
-65% -$191K ﹤0.01% 4047
2024
Q4 		$302K Buy
4,912
+3,795
+340% +$245K ﹤0.01% 3629
2024
Q3 		$74.7K Buy
1,117
+566
+103% +$38.4K ﹤0.01% 3531
2024
Q2 		$36.8K Sell
551
-7,848
-93% -$534K ﹤0.01% 3526
2024
Q1 		$597K Buy
8,399
+4,633
+123% +$348K ﹤0.01% 2753
2023
Q4 		$317K Buy
3,766
+1,899
+102% +$157K ﹤0.01% 3036
2023
Q3 		$161K Buy
1,867
+945
+102% +$87.2K ﹤0.01% 3177
2023
Q2 		$85.9K Sell
922
-519
-36% -$48.9K ﹤0.01% 3301
2023
Q1 		$137K Buy
1,441
+959
+199% +$88.1K ﹤0.01% 3250
2022
Q4 		$48.5K Sell
482
-558
-54% -$50.9K ﹤0.01% 3427
2022
Q3 		$88.7K Buy
1,040
+261
+34% +$23K ﹤0.01% 3820
2022
Q2 		$66.9K Buy
779
+385
+98% +$32.8K ﹤0.01% 3482
2022
Q1 		$35.4K Sell
394
-845
-68% -$77.7K ﹤0.01% 3620
2021
Q4 		$124K Buy
1,239
+370
+43% +$37.8K ﹤0.01% 3533
2021
Q3 		$80.7K Buy
869
+446
+105% +$39.4K ﹤0.01% 3356
2021
Q2 		$36K Sell
423
-249
-37% -$21.5K ﹤0.01% 3382
2021
Q1 		$58.2K Buy
672
+44
+7% +$3.87K ﹤0.01% 3566
2020
Q4 		$52.9K Sell
628
-150
-19% -$12.8K ﹤0.01% 3534
2020
Q3 		$62.1K Buy
778
+651
+513% +$54K ﹤0.01% 3370
2020
Q2 		$11.3K Sell
127
-958
-88% -$86K ﹤0.01% 3652
2020
Q1 		$102K Buy
1,085
+539
+99% +$50.1K ﹤0.01% 3195
2019
Q4 		$58.9K Sell
546
-12
-2% -$1.22K ﹤0.01% 3552
2019
Q3 		$53.5K Buy
558
+148
+36% +$13.8K ﹤0.01% 3440
2019
Q2 		$39.2K Sell
410
-309
-43% -$26K ﹤0.01% 3575
2019
Q1 		$63.5K Buy
719
+583
+429% +$51.3K ﹤0.01% 3375
2018
Q4 		$11.3K Sell
136
-119
-47% -$10.5K ﹤0.01% 3305
2018
Q3 		$24K Hold
255
– – ﹤0.01% 3340
2018
Q2 		$28.1K Sell
255
-514
-67% -$53.7K ﹤0.01% 3358
2018
Q1 		$76K Buy
769
+30
+4% +$2.68K ﹤0.01% 3330
2017
Q4 		$60.2K Buy
739
+385
+109% +$30.1K ﹤0.01% 3558
2017
Q3 		$26K Sell
354
-75
-17% -$5.39K ﹤0.01% 3459
2017
Q2 		$31.1K Buy
429
+268
+166% +$17.6K ﹤0.01% 3426
2017
Q1 		$10K Buy
161
+77
+92% +$4.85K ﹤0.01% 3174
2016
Q4 		$6.11K Sell
84
-137
-62% -$8.91K ﹤0.01% 3631
2016
Q3 		$13.2K Buy
221
+86
+64% +$5.47K ﹤0.01% 3092
2016
Q2 		$8.51K Buy
135
+94
+229% +$6.06K ﹤0.01% 2991
2016
Q1 		$2.56K Sell
41
-757
-95% -$44.6K ﹤0.01% 2374
2015
Q4 		$46.7K Sell
798
-129
-14% -$7.31K ﹤0.01% 2852
2015
Q3 		$49.9K Buy
927
+614
+196% +$33.5K ﹤0.01% 2864
2015
Q2 		$18.7K Buy
313
+225
+256% +$12.7K ﹤0.01% 3092
2015
Q1 		$5.27K Buy
+88
New +$5.17K ﹤0.01% 3128
2014
Q4 		– Sell
-161
Closed -$7.85K – 3155
2014
Q3 		$7.85K Buy
161
+133
+475% +$6.75K ﹤0.01% 3701
2014
Q2 		$1.44K Buy
+28
New +$1.44K ﹤0.01% 3287

Other funds holding UTMD

BIP
Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
MA
Minerva Advisors Bala Cynwyd, Pennsylvania $158M AUM 42.05% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BNP Paribas Financial Markets's UTMD Position: Q2 2026 in Review

BNP Paribas Financial Markets reduced its Utah Medical Products (UTMD) stake by 14% in Q2 2026, selling an estimated $11.4K and leaving 1,033 shares worth $71.3K. The position accounts for ﹤0.01% of the portfolio, ranked #4715.

BNP Paribas Financial Markets first reported a position in UTMD in Q2 2014 and has held it in 48 quarters since. The position peaked at $597K in Q1 2024. 107 funds tracked by Wall St. Rank hold UTMD as of Q2 2026.

  • BNP Paribas Financial Markets held 1,033 shares of Utah Medical Products worth $71.3K as of Q2 2026.
  • BNP Paribas Financial Markets sold 172 Utah Medical Products shares in Q2 2026, an estimated $11.4K.
  • Utah Medical Products made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #4715 holding.
  • BNP Paribas Financial Markets first reported a position in Utah Medical Products in Q2 2014 and has held it in 48 quarters since.
  • BNP Paribas Financial Markets's Utah Medical Products position peaked at $597K in Q1 2024.
  • 107 funds tracked by Wall St. Rank held Utah Medical Products as of Q2 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.